4/A

FORM 4/A SUBMISSION

Company: Ultragenyx Pharmaceutical Inc.
Filed: April 17, 2019
Period of Report: March 1, 2019
Accession Number: 0001209191-19-025104

View Document ↗ View on SEC.gov ↗